Showing results (561-570 of 576) with videos related to

Sort By:
Pageof 58
Haematologica|February 18, 2021
The miR-200c/141-ZEB2-TGFβ axis is aberrant in human T-cell prolymphocytic leukemiaStefan J Erkeland, Christiaan J Stavast, Joyce Schilperoord-Vermeulen, et al.
Nature Communications|October 3, 2020
Functional role of Tet-mediated RNA hydroxymethylcytosine in mouse ES cells and during differentiationJie Lan, Nicholas Rajan, Martin Bizet, et al.
Investigative Ophthalmology & Visual Science|September 8, 2018
Clinical Characterization of 66 Patients With Congenital Retinal Disease Due to the Deep-Intronic c.2991+1655A>G Mutation in CEP290Dyon Valkenburg, Caroline van Cauwenbergh, Birgit Lorenz, et al.
JAMA Oncology|November 25, 2020
Perceived Care and Well-being of Patients With Cancer and Matched Norm Participants in the COVID-19 Crisis: Results of a Survey of Participants in the Dutch PROFILES RegistryLonneke V van de Poll-Franse, Belle H de Rooij, Nicole J E Horevoorts, et al.
NPJ Breast Cancer|September 23, 2020
Polygenic risk score for the prediction of breast cancer is related to lesser terminal duct lobular unit involution of the breastClara Bodelon, Hannah Oh, Andriy Derkach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2012
Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657Laura J Esserman, Donald A Berry, Angela DeMichele, et al.
International Journal of Cancer|November 19, 2016
Association between breast cancer genetic susceptibility variants and terminal duct lobular unit involution of the breastClara Bodelon, Hannah Oh, Nilanjan Chatterjee, et al.
Breast Cancer Research and Treatment|June 26, 2016
Ages at menarche- and menopause-related genetic variants in relation to terminal duct lobular unit involution in normal breast tissueHannah Oh, Clara Bodelon, Maya Palakal, et al.
Leukemia|September 7, 2022
Prospective validation of a biomarker-driven response prediction model to romiplostim in lower-risk myelodysplastic neoplasms - results of the EUROPE trial by EMSCOAnne Sophie Kubasch, Aristoteles Giagounidis, Georgia Metzgeroth, et al.
Molecular Cell|December 8, 2023
SRSF2 plays an unexpected role as reader of m5C on mRNA, linking epitranscriptomics to cancerHai-Li Ma, Martin Bizet, Christelle Soares Da Costa, et al.
Pageof 58